Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 12;5(1):52.
doi: 10.1186/1758-5996-5-52.

Hypertension management algorithm for type 2 diabetic patients applied in primary care

Affiliations

Hypertension management algorithm for type 2 diabetic patients applied in primary care

Luciana V Viana et al. Diabetol Metab Syndr. .

Abstract

Background: Hypertension frequently coexists with type 2 diabetes (DM), and increases the risk of cardiovascular outcomes. The aim of the study was to obtain/maintain blood pressure (BP) goals (ADA/JNC 7) according to a stepwise algorithm using the medication supplied by the Brazilian government.

Methods: A one-year, single-arm interventional study conducted with type 2 diabetes patients. Intervention consisted of intensification of lifestyle changes and sequential prescription of drugs: diuretic; ACE inhibitors; β-adrenergic blocking agent and calcium channel blocking agent if BP >130/80 mmHg.

Results: Seventy-eight patients completed the trial. During intervention, the number of antihypertensive tablets rose (3.6 ± 3.5 vs. 5.9 ± 3.5 pills/patient; p <0.001), as the number of antihypertensive classes increased (1.8 ± 1.0 vs. 2.70 ± 1.2; p < 0.01) and the overall drop of BP was 11 mmHg for SBP (145.0 ± 22.8 vs. 133.7 ± 20.9 mmHg; p < 0.01) and 5 mmHg for DBP (78.7 ± 11.5 vs. 73.7 ± 10.5 mmHg; p = 0.001). Although the number of patients with BP in target almost doubled [14 (18.7%) vs. 30 (38.5%) p = 0.008], less than 40% of the patients achieved the proposed goals.

Conclusions: A BP algorithm applied to type 2 diabetic and hypertensive patients is able to lower BP, however more than half of the patients did not achieve the ADA/JNC 7 targets demonstrating the complexity of BP control in this population.

Trial registration: ClinicalTrials.gov: NCT06260.

Trial registration: ClinicalTrials.gov NCT00006260.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Blood Pressure decrease and Medication Tablets increase throughout the study: Panel A – Systolic Blood Pressure (mean ± SE); *Run-In: Systolic BP: 145.0 ± 22.8 vs. 138.8 ± 21.2 mmHg; p = 0.002; ** Intervention Systolic BP: 138.5 ± 21.21 to 132.6 ± 14.8 mmHg; P = 0.046; Panel B – Diastolic Blood Pressure (mean ± SE). +Run-In: Diastolic BP: 79.4 ± 11.5 vs. 76.5 ± 10.9; p = 0.026; ++ Intervention Diastolic BP: 76.4 ± 11.05 to 74.4 ± 8.6; P <0.01.

References

    1. Mancia G. The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction. Acta Diabetol. 2005;42:S17–S25. doi: 10.1007/s00592-005-0177-z. - DOI - PubMed
    1. UK Prospective Diabetes Study Group. Tight blood pressure control and the risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703–713. doi: 10.1136/bmj.317.7160.703. - DOI - PMC - PubMed
    1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003;289:2560–2572. doi: 10.1001/jama.289.19.2560. - DOI - PubMed
    1. American Diabetes Association. Standards of medical care in diabetes, 2010. Diabetes Care. 2010;34:S11–S61. - PMC - PubMed
    1. Pinto LC, Ricardo ED, Leitão CB, Kramer CK, Zanatta CM, Gross JL, Canani LH. Control inadecuado de la presion arterial en pacientes con diabetes melito tipo 2. Arq Bras Cardiol. 2010;94:633–637. doi: 10.1590/S0066-782X2010005000029. - DOI - PubMed

Associated data